IL-10- and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5138-5144

  Hellings, Peter W ^a   Kasran, Ahmad ^a   Bullens, Dominique ^a   Overbergh, Lutgart ^a   Mathieu, Chantal ^a   Heremans, Hubertine ^a   Matthys, Patrick ^a   Boon, Louis ^b   Jorissen, Mark ^a   Ceuppens, Jan L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Pangenetics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHILIA; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 33749521456     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5138     Document Type: Article

References (51)

1. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 185: 341-349.
2. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16: 111-135.
3. Mackey, M. F., R. J. Barth, Jr., and R. J. Noelle. 1998. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukocyte Biol. 63: 418-428.
4. Stamenkovic, I., E. A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8: 1403-1410.
5. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291-300.
6. Ruedl, C., M. F. Bachmann, and M. Kopf. 2000. The antigen dose determines T helper subset development by regulation of CD40 ligand. Eur. J. Immunol. 30; 2056-2064.
7. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180: 1263-1272.
8. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorïni, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16: 495-521.
9. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752.
10. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: up-regulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J. Exp. Med. 184: 741-746.
11. Flamand, V., V. Donckier, F. X. Demoor, A. Le Moine, P. Matthys, M. L. Vanderhaeghen, Y. Tagawa, Y. Iwakura, A. Billiau, D. Abramowicz, and M. Goldman. 1998. CD40 ligation prevents neonatal induction of transplantation tolerance. J. Immunol. 160: 4666-4669.
12. Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter, and R. J. Noëlle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328-1330.
13. Balasa, B., T. Krahl, G. Patstone, J. Lee, R. Tisch, H. O. McDevitt, and N. Sarvetnick. 1997. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159: 4620-4627.
14. Mohan, C., Y. Shi, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154: 1470-1480.
15. Howard, L. M., A. J. Miga, C. L. Vanderlugt, M. C. Dal Canto, J. D. Laman, R. J. Noelle, and S. D. Miller. 1999. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103: 281-290.
16. Griggs, N. D., S. S. Agersborg, R. J. Noelle, J. A. Ledbetter, P. S. Linsley, and K. S. Tung. 1996. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183: 801-810.
17. + T cells by blocking the CD40-CD154 interactions. J. Immunol. 164: 6005-6014.
18. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378: 617-620.
19. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4: 283-289.
20. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4: 263-273.
21. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J. Immunol. 158: 29-39.
22. Ferlin, W. G., T. von der Weid, F. Cottrez, D. A. Ferrick, R. L. Coffman, and M. C. Howard. 1998. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur. J. Immunol. 28: 525-531.
23. Martin, D. L., C. L. King, E. Pearlman, E. Strine, and F. P. Heinzel. 2000. IFN-γ is necessary but not sufficient for anti-CD40 antibody-mediated inhibition of the Th2 response to Schistosoma mansoni eggs. J. Immunol. 164: 779-785.
24. Turner, J. G., A. L. Rakhmilevich, L. Burdelya, Z. Neal, M. Imboden, P. M. Sondel, and H. Yu. 2001. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells. J. Immunol. 166: 89-94.
25. Gurunathan, S., K. R. Irvine, C. Y. Wu, J. I. Cohen, E. Thomas, C. Prussin, N. P. Restifo, and R. A. Seder. 1998. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J. Immunol. 161: 4563-4571.
26. Busse, W. W., and R. F. Lemanske, Jr. 2001. Asthma. N. Engl. J. Med. 344: 350-362.
27. Jaffar, Z. H., L. Stanciu, A. Pandit, J. Lordan, S. T. Holgate, and K. Roberts. 1999. Essential role for both CD80 and CD86 costimulation, but not CD40 interactions, in allergen-induced Th2 cytokine production from asthmatic bronchial tissue: role for αβ, but not γδ, T cells. J. Immunol. 163: 6283-6291.
28. Mehlhop, P. D., M. van de Rijn, J. P. Brewer, A. B. Kisselgof, R. S. Geha, H. C. Oettgen, and T. R. Martin. 2000. CD40L, but not CD40, is required for allergen-induced bronchial hyperresponsiveness in mice. Am. J. Respir. Cell Mol. Biol. 23: 646-651.
29. Tang, C., C. Ward, D. Reid, R. Bish, P. M. O'Byrne, and E. H. Walters. 2001. Normally suppressing CD40 coregulatory signals delivered by airway macrophages to TH2 lymphocytes are defective in patients with atopic asthma. J. Allergy Clin. Immunol. 107: 863-870.
30. Hogan, S. P., A. Mould, H. Kikutani, A. J. Ramsay, and P. S. Foster. 1997. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 99: 1329-1339.
31. + T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis. J. Allergy Clin. Immunol. 107: 359-366.
32. Rolink, A., F. Melchers, and J. Andersson. 1996. The SCID but not the RAG-2 gene product is required for Sμ-Sε heavy chain class switching. Immunity 5: 319-330.
33. Mauri, C., L. T. Mars, and M. Londei. 2000. Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process. Nat. Med. 6: 673-679.
34. Hellings, P. W., E. M. Hessel, J. Van den Oord, A. Kasran, P. Van Hecke, and J. L. Ceuppens. 2001. Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyperreactivity in sensitized mice exposed to aerosolized allergen. Clin. Exp. Allergy 31: 782-790.
35. Heremans, H., C. Dillen, M. Groenen, P. Matthys, and A. Billiau. 1999. Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice. Eur. Cytokine Network 10: 171-180.
36. Overbergh, L., D. Valckx, M. Waer, and C. Mathieu. 1999. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11: 305-312.
37. Hellings, P. W., P. Vandenberghe, A. Kasran, L. Coorevits, L. Overbergh, C. Mathieu, and J. L. Ceuppens. 2002. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur. J. Immunol. 32: 585-594.
38. Gavett, S. H., D. J. O'Hearn, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182: 1527-1536.
39. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
40. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183: 109-117.
41. Kuipers, H., D. Hijdra, V. C. De Vries, H. Hammad, J. B. Prins, A. J. Coyle, H. C. Hoogsteden, and B. N. Lambrecht. 2003. Lipopolysaccharide-induced suppression of airway Tri2 responses does not require IL-12 production by dendritic cells. J. Immunol. 171: 3645-3654.
42. De Vries, J. E. 1995. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27: 537-541.
43. Pretolani, M., and M. Goldman. 1997. IL-10: a potential therapy for allergic inflammation? Immunol. Today 18: 277-280.
44. Makela, M. J., A. Kanehiro, L. Borish, A. Dakhama, J. Loader, A. Joetham, Z. Xing, M. Jordana, G. L. Larsen, and E. W. Gelfand. 2000. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc. Natl. Acad. Sci. USA 97: 6007-6012.
45. + T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105: 61-70.
46. Walter, D. M., C. P. Wong, R. H. DeKruyff, G. J. Berry, S. Levy, and D. T. Umetsu. 2001. IL-18 gene transfer by adenovirus prevents the development of and reverses established allergen-induced airway hyperreactivity. J. Immunol. 166: 6392-6398.
47. Quesniaux, V. F., and B. Ryffel. 1996. Interleukin-12-induced interferon-γ inhibits hematopoiesis in vivo in mice. Ann. NY Acad. Sci. 795: 189-195.
48. Galy, A. H., and H. Spits. 1992. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149: 775-782.
49. Varney, V. A., Q. A. Hamid, M. Gaga, S. Ying, M. Jacobson, A. J. Frew, A. B. Kay, and S. R. Durham. 1993. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J. Clin. Invest. 92: 644-651.
50. + T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J. Allergy Clin. Immunol. 97: 1356-1365.
51. Bryan, S. A., B. J. O'Connor, S. Matti, M. J. Leckie, V. Kanabar, J. Khan, S. J. Warrington, L. Renzetti, A. Rames, J. A. Bock, et al. 2000. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356: 2149-2153.